Relationship of the revised anticholinergic drug scale with cultured cell-based serum anticholinergic activity and cognitive measures in older adults with mild cognitive impairment or remitted depression.
Saved in:
| Title: | Relationship of the revised anticholinergic drug scale with cultured cell-based serum anticholinergic activity and cognitive measures in older adults with mild cognitive impairment or remitted depression. |
|---|---|
| Authors: | Carnahan RM; Department of Epidemiology, The University of Iowa College of Public Health, Iowa City, Iowa, USA., Chandramouleeshwaran S; Department of Psychiatry, University of Ottawa, Ottawa, Ontario, Canada., Ahsan N; Centre for Addiction and Mental Health, Toronto, Ontario, Canada., Raymond R; Centre for Addiction and Mental Health, Toronto, Ontario, Canada., Nobrega JN; Centre for Addiction and Mental Health, Toronto, Ontario, Canada., Wang W; Centre for Addiction and Mental Health, Toronto, Ontario, Canada., Fischer CE; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.; Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, Ontario, Canada.; Toronto Dementia Research Alliance, University of Toronto, Toronto, Ontario, Canada., Flint AJ; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.; Centre for Mental Health, University Health Network, Toronto, Ontario, Canada., Herrmann N; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.; Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Kumar S; Centre for Addiction and Mental Health, Toronto, Ontario, Canada.; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.; Toronto Dementia Research Alliance, University of Toronto, Toronto, Ontario, Canada., Lanctôt KL; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.; Toronto Dementia Research Alliance, University of Toronto, Toronto, Ontario, Canada.; Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Mah L; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.; Rotman Research Institute, Baycrest Health Sciences Centre, Toronto, Ontario, Canada., Mulsant BH; Centre for Addiction and Mental Health, Toronto, Ontario, Canada.; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.; Toronto Dementia Research Alliance, University of Toronto, Toronto, Ontario, Canada., Pollock BG; Centre for Addiction and Mental Health, Toronto, Ontario, Canada.; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.; Toronto Dementia Research Alliance, University of Toronto, Toronto, Ontario, Canada., Rajji TK; Centre for Addiction and Mental Health, Toronto, Ontario, Canada.; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.; Toronto Dementia Research Alliance, University of Toronto, Toronto, Ontario, Canada. |
| Source: | Pharmacotherapy [Pharmacotherapy] 2025 Jun; Vol. 45 (6), pp. 332-340. Date of Electronic Publication: 2025 May 06. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 8111305 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1875-9114 (Electronic) Linking ISSN: 02770008 NLM ISO Abbreviation: Pharmacotherapy Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1875-9114 |
|---|---|
| DOI: | 10.1002/phar.70022 |
